Diagnostics Inc reports results for the quarter ended in January - Earnings Summary

Co-Diagnostics

09/05/2024 22:02

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 31 cents​​ per share for the quarter ended in January, lower
than the same quarter last year, when the company reported EPS
of -20 cents.  The lone analyst forecast for the quarter was
for a loss of 21 cents per share. 
    * Revenue fell 22.2% to $467.85 thousand from a year ago;
analysts
expected $3.05 million. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The company reported a quarterly loss of $9.31 million.
    * Co-Diagnostics Inc shares had risen by 8.9% this
quarter and
lost 8.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $2.50 

This summary was machine generated from LSEG data May 9 at 09:01
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.21          -0.31          Missed
 Dec. 31 2023      -0.20          -0.50          Missed
 Sep. 30 2023      -0.29          -0.20          Beat
 Jun. 30 2023      -0.24          -0.31          Missed